INVESTIGATIONS AND REPORTS RESPECTING FDA REGULATION OF NEW DRUGS .2.

被引：5

作者：

HUTT, PB ^{[1
]}

机构：

[1] COVINGTON & BURLING,WASHINGTON,DC

来源：

关键词：

D O I：

10.1038/clpt.1983.92

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：674 / 687

页数：14

共 82 条

[1] COOK J, 1980, OPE57 FDA OFF PLANN
[2] THE DECLINE IN EFFECTIVE PATENT LIFE OF NEW DRUGS
EISMAN, MM
WARDELL, WM
[J]. RESEARCH MANAGEMENT, 1981, 24 (01): : 18 - 21
[3] FEA Task Force on Compliance and Enforcement, 1977, FINAL REPORT
[4] GRABOWSKI HG, 1976, AEI28 AM ENT I EV ST
[5] HALPERIN J, 1982, METHODS VALIDATION F
[6] HALPERIN J, 1981, PREDICTIONS PHARM RE
[7] HALPERIN J, 1981, METHODS VALIDATION
[8] Hansen R, 1979, ISSUES PHARM EC
[9] HASS AE, 1982, OPE60 FDA OFF PLANN
[10] HAYES AH, 1982, ORG CHANGES MERGER B